NovoLog Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

• News
• Research
• Blogs
• Alerts
• Clinical Trials
• Forums

Safety Assessment of SAR341402 and NovoLog ® Used in Continuous Subcutaneous Insulin Infusion for Type 1 Diabetes Mellitus Patients
Condition:   Type 1 Diabetes Mellitus Interventions:   Drug: Insulin aspart SAR341402;   Drug: Insulin aspart Sponsor:   Sanofi Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 16, 2018 Category: Research Source Type: clinical trials

Research Study Comparing a New Medicine " Fast-acting Insulin Aspart " to Another Already Available Medicine " NovoRapid " / " NovoLog " in People With Type 2 Diabetes
Conditions:   Diabetes;   Diabetes Mellitus, Type 2 Interventions:   Drug: Faster-acting insulin aspart;   Drug: Insulin aspart;   Drug: Insulin degludec;   Drug: Metformin Sponsor:   Novo Nordisk A/S Not yet recruiting - verified August 2017 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 29, 2017 Category: Research Source Type: clinical trials